FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/01/2026
Voltar para busca
Dado oficial do USPTO
MACUMIRA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 10, 41, 44
Data de depósito
13/03/2024
Data de registro
10/06/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/06/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
CA
Examinador
BLAKESLEE, RICHARD A
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of a design composed of a solid blue circle surrounded by two curving bars in blue and light blue, next to the wording "MACUMIRA" in black stylized font, all on a white background.
Titulares e representantes
Titulares
MacuMira Medical Devices Inc.
Representantes
David S. Kerr Berg Hill Greenleaf Ruscitti LLP
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 41Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Optical deviceseye pieces for helmet mounted displays.
Classe 10
Apparatus for transcutaneous electrical nerve stimulation; electrical nerve muscle stimulators; electrodes for medical purposes; electrodes for medical use; electronic muscle stimulators for medical purposes; electronic nerve stimulators for medical purposes; low frequency electric therapy apparatus; medical electrodes; neural helmets for medical purposes in the nature of electroencephalography (EEG) helmets for monitoring and measuring brain activity for medical diagnostic purposes; optometric instrumentsinstruments for bioelectric modulation and micro-electrical stimulation therapy for retinal healthvisual improvementthe treatment of ophthalmic diseasesin particularretinal disorders and other degenerative eye conditions
Classe 41
Educational servicesconducting workshopsseminarstraining programsonline courses for healthcare professionals and patients in in the field of eye care and eye treatment productsophthalmic treatmentsbioelectric modulationmicro-current stimulation for retinal health and visual improvement; educational servicesconducting workshopsseminarstraining programsonline courses for healthcare professionals and patients in the fields of eye careeye treatmenteye diagnosis; educational training sessionsseminarsconferences in the field of eye care and eye treatment products; educational training sessionsseminarsconferences in the prevention and treatment of ophthalmic diseasesbioelectric modulationmicro-current stimulation for retinal health and visual improvementdisorders and treatment products
Classe 44
Comprehensive health care services for diagnosing and treating eye disease; medical analysis services for dry eye disease preventionscreeningdiagnosis and treatment; providing medical information in relation to the treatment and prevention of ophthalmic diseases and disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/01/2026
FIMP
FINAL DISPOSITION PROCESSED
10/01/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/11/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/10/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/10/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/09/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/06/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/04/2025
PUBO
PUBLISHED FOR OPPOSITION
22/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/04/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/03/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
25/03/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/03/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
25/03/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/03/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/03/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/03/2025
RFNT
REFUSAL PROCESSED BY IB
19/10/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/09/2024
RFRR
REFUSAL PROCESSED BY MPU
30/09/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/09/2024
CNRT
NON-FINAL ACTION WRITTEN
25/09/2024
DOCK
ASSIGNED TO EXAMINER
24/09/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/07/2024
MAFR
APPLICATION FILING RECEIPT MAILED
29/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/05/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/05/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MACUMIRA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.